Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × Mitomycin × 1 year × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 10 Non-Muscle Invasive Bladder Neoplasms 9 Anus Neoplasms 6 Colorectal Neoplasms 5 Appendiceal Neoplasms 5 Peritoneal Neoplasms 4 Carcinoma, Transitional Cell 3 Stomach Neoplasms 2 Pseudomyxoma Peritonei 2 Ovarian Neoplasms 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pleural Neoplasms 1 Neoplasm Metastasis 1 Necrosis 1 Nasopharyngeal Carcinoma 1 Mediastinal Neoplasms 1 Lung Metastases 1 Locally Advanced Anal Canal Cancer 1 Liver Neoplasms 1 HIV Infections 1 Gastrointestinal Neoplasms 1 Epstein-Barr Virus Infections 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1

Interventions

pembrolizumab 2 atezolizumab 2 zenocutuzumab 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 entrectinib 1 cobimetinib 1 alectinib 1 Whole Genome Sequencing 1 Vemurafenib 1 Transurethral Resection of Prostate 1 Specimen Handling 1 Sequence Analysis, RNA 1 Radiosurgery 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 HhAntag691 1 Genetic Testing 1 Genetic Profile 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Erlotinib Hydrochloride 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡